We are live on
!
Find out more
OASM
Oasmia Pharmaceutical AB
OASM
OASM
Delisted
OASM was delisted on the 21st of August, 2019.
6 hedge funds and large institutions have $226K invested in Oasmia Pharmaceutical AB in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
50% more funds holding
Funds holding: 4 → 6 (+2)
11% less capital invested
Capital invested by funds: $253K → $226K (-$27K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$17.8K |
| 2 |
Bank of New York Mellon
New York
|
+$13K |
| 3 |
Morgan Stanley
New York
|
+$1 |
Top Sellers
| 1 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$18K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.54K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SCM
1
Sio Capital Management
New York
| $179K | – | – | – |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $17K | – | – | – |
|
|
3
Citadel Advisors
Miami,
Florida
| $16K | +$17.8K | +18,488 | New |
|
|
4
Bank of New York Mellon
New York
| $12K | +$13K | +13,450 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $2K | -$1.54K | -1,602 | -44% |
|
|
OMC
6
Old Mission Capital
Chicago,
Illinois
| – | -$18K | -16,919 | Closed |
|
|
7
Morgan Stanley
New York
| – | +$1 | +1 | New |
|